Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

OBJECTIVES: Biomarkers for invasive fungal disease (IFD) have been shown to reduce antifungal prescriptions in neutropaenic haemato-oncology patients. Our study aimed to assess the real-life impacts of introducing a novel biomarker-based pathway, incorporating serum galactomannan and Aspergillus PCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinelli, Anthony W., Wright, Callum B., Lopes, Marta S., Swayne, Rosemary L., Krishnamurthy, Pramila, Crawley, Charles, Uttenthal, Ben, Follows, George, Babar, Judith, Aliyu, Sani H., Enoch, David A., Sander, Clare R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613179/
https://www.ncbi.nlm.nih.gov/pubmed/35819894
http://dx.doi.org/10.1099/jmm.0.001564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613179/
https://www.ncbi.nlm.nih.gov/pubmed/35819894
http://dx.doi.org/10.1099/jmm.0.001564

Ejemplares similares